πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 50 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10851358

Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom

Precision BioSciences, Inc. Β· Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799535

Engineered meganucleases with recognition sequences found in the human T cell receptor alp

Precision BioSciences, Inc. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662416

Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom

Precision BioSciences, Inc. Β· Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10632180

Methods and compositions for improved cognition

The Regents of the University of California Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10603326

Pharmaceutical formulation of 3Ξ±-ethynyl-3Ξ²-hydroxyandrostan-17-one oxime

Umecrine Cognition AB Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10351589

3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CN

Umecrine Cognition AB Β· Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342804

Steroid compound for use in the treatment of hepatic encephalopathy

Umecrine Cognition AB Β· Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300117

Methods and compositions for improved cognition

The Regents of the University of California Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10278977

Methods for treating hypersomnolence

Umecrine Cognition AB Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10086091

Method of preparation of biodegradable nanoparticles with recognition characteristics

The Board of Regents of the University of Texas System Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10041053

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. Β· Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801894

Steroid compound for use in the treatment of hepatic encephalopathy

Umecrine Cognition AB Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585910

Polymers functionalized with ion-specific recognition elements

The Board of Regents of the University of Texas System Β· Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9434931

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340777

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9200028

Steroids having increased water solubility and resistance against metabolism and methods f

Umecrine Cognition AB Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865723

Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

Tetra Discovery Partners Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802074

Polymers functionalized with ion-specific recognition elements

The Board of Regents of the University of Texas System Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445251

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7708987

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors

The United States of America as represented by the Department of Health and Human Services (DHHS) Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619005

Methods for treating cognitive impairment in humans with Multiple Sclerosis

Cognition Pharmaceuticals, LLC Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452723

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244769

Methods for treating an impairment in memory consolidation

Cognition Pharmaceuticals, LLC Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted